Medtronic had two patents in ecommerce during Q2 2024. Medtronic Plc’s patents in Q2 2024 focus on innovative techniques for therapy delivery, including modifying treatment schedules or treatments based on recommendations from a simulator, ultimately improving patient care and outcomes. GlobalData’s report on Medtronic gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Medtronic had no grants in ecommerce as a theme in Q2 2024.
Recent Patents
Application: Methods and systems for therapy delivery (Patent ID: US20240181158A1)
The patent filed by Medtronic Plc relates to techniques for therapy delivery, specifically focusing on determining modifications to therapy information based on recommendations from a simulator. The system described includes a delivery device executing therapy information with a treatment schedule and treatments, along with processing circuitry that determines and provides modifications to the therapy information, such as adjusted treatment schedules or treatments, based on simulator recommendations. The simulator can predict glucose information for patients, and modifications are selected based on this predicted data, potentially improving therapy outcomes.
Additionally, the system involves patient-specific models within the simulator to tailor modifications based on individual patient data. The processing circuitry can output device settings or instructions to the delivery device for implementing modifications, subject to physician approval. Furthermore, the system allows for the transmission of modification data to healthcare providers for collaborative decision-making. The method outlined in the patent involves determining modifications to therapy information, providing these modifications, and potentially refining initial modifications based on simulator recommendations. Overall, the patent aims to enhance therapy delivery by leveraging simulator predictions and patient-specific data to optimize treatment schedules and treatments, ultimately improving patient outcomes and healthcare service efficiency.
To know more about GlobalData’s detailed insights on Medtronic, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
